Characterizing the Natural History of Pediatric Brain Tumors Presenting with Metastasis
Simple Summary
Abstract
1. Introduction
2. Methods
2.1. Patient Selection
2.2. Data and Outcomes
2.3. Statistical Analyses
3. Results
3.1. Demographics
3.2. Clinical Features
3.3. Treatment Features
3.4. Overall Survival and Predictors
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Udaka, Y.T.; Packer, R.J. Pediatric Brain Tumors. Neurol. Clin. 2018, 36, 533–556. [Google Scholar] [CrossRef] [PubMed]
- Pollack, I.F. Brain tumors in children. N. Engl. J. Med. 1994, 331, 1500–1507. [Google Scholar] [CrossRef] [PubMed]
- Ostrom, Q.T.; Price, M.; Ryan, K.; Edelson, J.; Neff, C.; Cioffi, G.; Waite, K.A.; Kruchko, C.; Barnholtz-Sloan, J.S. CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018. Neuro-Oncology 2022, 24, iii1–iii38. [Google Scholar] [CrossRef] [PubMed]
- Awan, M.; Liu, S.; Sahgal, A.; Das, S.; Chao, S.T.; Chang, E.L.; Knisely, J.P.; Redmond, K.; Sohn, J.W.; Machtay, M.; et al. Extra-CNS metastasis from glioblastoma: A rare clinical entity. Expert. Rev. Anticancer Ther. 2015, 15, 545–552. [Google Scholar] [CrossRef]
- Amitendu, S.; Mak, S.K.; Ling, J.M.; Ng, W.H. A single institution experience of the incidence of extracranial metastasis in glioma. J. Clin. Neurosci. 2012, 19, 1511–1515. [Google Scholar] [CrossRef]
- Zapotocky, M.; Mata-Mbemba, D.; Sumerauer, D.; Liby, P.; Lassaletta, A.; Zamecnik, J.; Krskova, L.; Kyncl, M.; Stary, J.; Laughlin, S.; et al. Differential patterns of metastatic dissemination across medulloblastoma subgroups. J. Neurosurg. Pediatr. PED 2018, 21, 145–152. [Google Scholar] [CrossRef]
- Varan, A.; Sari, N.; Akalan, N.; Söylemezoğlu, F.; Akyüz, C.; Kutluk, T.; Büyükpamukçu, M. Extraneural metastasis in intracranial tumors in children: The experience of a single center. J. Neurooncol. 2006, 79, 187–190. [Google Scholar] [CrossRef]
- Silva, A.H.D.; Habermann, S.; Craven, C.L.; Bhagawati, D.; O’Hare, P.; Jorgensen, M.; Dahl, C.; Mankad, K.; Thompson, D.N.P.; Hargrave, D.; et al. Atypical teratoid rhabdoid tumours (ATRTs)-a 21-year institutional experience. Childs Nerv. Syst. 2023, 39, 1509–1518. [Google Scholar] [CrossRef]
- Güler, E.; Varan, A.; Söylemezoglu, F.; Caglar, K.; Başaran Demirkazik, F.; Büyükpamukçu, M. Extraneural metastasis in a child with atypical teratoid rhabdoid tumor of the central nervous system. J. Neurooncol. 2001, 54, 53–56. [Google Scholar] [CrossRef]
- Wang, S.; Sun, M.Z.; Abecassis, I.J.; Weil, A.G.; Ibrahim, G.M.; Fallah, A.; Ene, C.; Leary, S.E.S.; Cole, B.L.; Lockwood, C.M.; et al. Predictors of mortality and tumor recurrence in desmoplastic infantile ganglioglioma and astrocytoma-and individual participant data meta-analysis (IPDMA). J. Neurooncol. 2021, 155, 155–163. [Google Scholar] [CrossRef]
- Liu, Z.; Feng, S.; Li, J.; Cao, H.; Huang, J.; Fan, F.; Cheng, L.; Liu, Z.; Cheng, Q. The Epidemiological Characteristics and Prognostic Factors of Low-Grade Brainstem Glioma: A Real-World Study of Pediatric and Adult Patients. Front. Oncol. 2020, 10, 391. [Google Scholar] [CrossRef]
- Wong, G.C.; Li, K.K.; Wang, W.W.; Liu, A.P.; Huang, Q.J.; Chan, A.K.; Poon, M.F.; Chung, N.Y.; Wong, Q.H.; Chen, H.; et al. Clinical and mutational profiles of adult medulloblastoma groups. Acta Neuropathol. Commun. 2020, 8, 191. [Google Scholar] [CrossRef] [PubMed]
- Lerro, C.C.; Robbins, A.S.; Phillips, J.L.; Stewart, A.K. Comparison of cases captured in the national cancer data base with those in population-based central cancer registries. Ann. Surg. Oncol. 2013, 20, 1759–1765. [Google Scholar] [CrossRef] [PubMed]
- Rickert, C.H. Extraneural metastases of paediatric brain tumours. Acta Neuropathol. 2003, 105, 309–327. [Google Scholar] [CrossRef]
- Yamasaki, K.; Kiyotani, C.; Terashima, K.; Watanabe, Y.; Kanamori, M.; Koga, Y.; Hata, N.; Iwasaki, F.; Goto, H.; Koh, K.; et al. Clinical characteristics, treatment, and survival outcome in pediatric patients with atypical teratoid/rhabdoid tumors: A retrospective study by the Japan Children’s Cancer Group. J. Neurosurg. Pediatr. 2019, 25, 111–120. [Google Scholar] [CrossRef]
- Yang, J.; Kwon, J.W.; Shin, S.H.; Yoo, H.; Wang, K.C.; Lee, S.H.; Gwak, H.S. Leptomeningeal Metastasis in Gliomas: Clinical Characteristics and Risk Factors. J. Korean Neurosurg. Soc. 2023, 66, 465–475. [Google Scholar] [CrossRef]
- Dressler, E.V.; Dolecek, T.A.; Liu, M.; Villano, J.L. Demographics, patterns of care, and survival in pediatric medulloblastoma. J. Neurooncol. 2017, 132, 497–506. [Google Scholar] [CrossRef]
- Tran, H.; Coven, S.L.; Park, S.; Mendonca, E.A. Social determinants of health and pediatric cancer survival: A systematic review. Pediatr. Blood Cancer 2022, 69, e29546. [Google Scholar] [CrossRef]
- Sasaki, T.; Uematsu, Y.; Fukai, J.; Tanaka, S.; Mukasa, A.; Saito, N.; Narita, Y.; Nakao, N. Prognostic Factors and Histopathological Features of Pediatric Intracranial Ependymomas: Nationwide Brain Tumor Registry-based Study of Japan. Neurol. Med. Chir. 2022, 62, 322–327. [Google Scholar] [CrossRef]
- Chen, Z.; Guo, Z.; Wang, J.; Cao, D.; Xu, Y.; Dong, F.; Wan, F. Clinical features and outcomes of pediatric intracranial gliomas: Results from single center’s 226 cases and corroborated with SEER database. Childs Nerv. Syst. 2023, 39, 593–601. [Google Scholar] [CrossRef]
- Ruiz-Garcia, H.; Huayllani, M.T.; Incontri, D.; Whaley, J.J.; Marenco-Hillembrand, L.; Ebot, J.; Chaichana, K.L.; Sheehan, J.; Quiñones-Hinojosa, A.; Trifiletti, D.M. Intraventricular choroid plexus tumors: Clinical characteristics and impact of current management on survival. J. Neurooncol. 2020, 149, 283–292. [Google Scholar] [CrossRef] [PubMed]
- Lu, V.M.; Di, L.; Eichberg, D.G.; Luther, E.M.; Shah, A.H.; Daniels, D.J.; Maher, O.M.; Niazi, T.N. Age of diagnosis clinically differentiates atypical teratoid/rhabdoid tumors diagnosed below age of 3 years: A database study. Childs Nerv. Syst. 2021, 37, 1077–1085. [Google Scholar] [CrossRef] [PubMed]
- Miller, K.E.; Wheeler, G.; LaHaye, S.; Schieffer, K.M.; Cearlock, S.; Venkata, L.P.R.; Bravo, A.O.; Grischow, O.E.; Kelly, B.J.; White, P.; et al. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front. Oncol. 2022, 12, 932337. [Google Scholar] [CrossRef]
- Demirkaya, M.; Sevinir, B.; Güler, S.; Demiröz, C.; Taskapilioglu, Ö.; Yilmazlar, S.; Palabiyik, F.; Tolunay, S. Leptomeningeal dissemination and vertebral bone involvement in a child with pilocytic astrocytoma. Pediatr. Int. 2016, 58, 1341–1344. [Google Scholar] [CrossRef]
- Arulrajah, S.; Huisman, T.A. Pilomyxoid astrocytoma of the spinal cord with cerebrospinal fluid and peritoneal metastasis. Neuropediatrics 2008, 39, 243–245. [Google Scholar] [CrossRef]
- Horbinski, C.; Ligon, K.L.; Brastianos, P.; Huse, J.T.; Venere, M.; Chang, S.; Buckner, J.; Cloughesy, T.; Jenkins, R.B.; Giannini, C.; et al. The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients. Neuro Oncol. 2019, 21, 1498–1508. [Google Scholar] [CrossRef]
- Nonnenbroich, L.F.; Bouchal, S.M.; Millesi, E.; Rechberger, J.S.; Khatua, S.; Daniels, D.J. H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions. Cells 2024, 13, 11–22. [Google Scholar] [CrossRef]
- Louis, D.N.; Perry, A.; Wesseling, P.; Brat, D.J.; Cree, I.A.; Figarella-Branger, D.; Hawkins, C.; Ng, H.K.; Pfister, S.M.; Reifenberger, G.; et al. The 2021 WHO Classification of Tumors of the Central Nervous System: A summary. Neuro-Oncology 2021, 23, 1231–1251. [Google Scholar] [CrossRef]
- Van den Bent, M.J.; Smits, M.; Kros, J.M.; Chang, S.M. Diffuse Infiltrating Oligodendroglioma and Astrocytoma. J. Clin. Oncol. 2017, 35, 2394–2401. [Google Scholar] [CrossRef]
- Lu, V.M.; Di, L.; Gernsback, J.; Eichberg, D.G.; Luther, E.M.; Shah, A.H.; Daniels, D.J.; Maher, O.M.; Niazi, T.N. Contemporary outcomes of diffuse leptomeningeal glioneuronal tumor in pediatric patients: A case series and literature review. Clin. Neurol. Neurosurg. 2022, 218, 107265. [Google Scholar] [CrossRef]
All Patients (n = 8615) | Metastasis Present (n = 356) | Metastasis Absent (n = 8259) | p | |
---|---|---|---|---|
Demographic features | ||||
Age (years) | 8.8 ± 5.5 | 6.0 ± 4.6 | 8.9 ± 5.5 | <0.001 |
Gender | <0.001 | |||
Female | 3901 (45%) | 117 (33%) | 3784 (46%) | |
Male | 4714 (55%) | 239 (67%) | 4475 (54%) | |
Race | 0.054 | |||
White | 6573 (76%) | 266 (75%) | 6306 (76%) | |
Black | 1115 (13%) | 38 (11%) | 1077 (13%) | |
Other | 927 (11%) | 52 (14%) | 876 (11%) | |
Hispanic status | 0.098 | |||
Hispanic | 1555 (18%) | 76 (21%) | 1479 (18%) | |
Non-Hispanic | 7060 (82%) | 280 (79%) | 6780 (82%) | |
Insurance status | 0.001 | |||
Private | 5177 (60%) | 178 (50%) | 4999 (61%) | |
Medicaid/Medicare | 2915 (34%) | 154 (43%) | 2761 (33%) | |
Other | 333 (4%) | 16 (4%) | 317 (4%) | |
None | 190 (2%) | 8 (2%) | 182 (2%) | |
Family annual income | 0.052 | |||
>$63,333 | 3177 (37%) | 110 (31%) | 3067 (37%) | |
$50,354–$63,332 | 1958 (23%) | 97 (28%) | 1861 (23%) | |
$40,227–$50,353 | 1836 (22%) | 72 (21%) | 1764 (22%) | |
<$40,227 | 1565 (18%) | 71 (20%) | 1494 (18%) | |
Parent education level | 0.134 | |||
<6.3% | 2124 (25%) | 72 (20%) | 2052 (25%) | |
6.3–10.8% | 2234 (26%) | 88 (25%) | 2146 (26%) | |
10.9–17.5% | 2113 (25%) | 100 (28%) | 2013 (25%) | |
>17.6% | 2075 (24%) | 92 (26%) | 1983 (24%) | |
Residence | 0.266 | |||
Metropolitan | 7179 (83%) | 289 (81%) | 6890 (83%) | |
Urban/rural | 1436 (17%) | 167 (19%) | 1369 (16%) | |
Co-morbidity | 0.207 | |||
Yes | 872 (10%) | 29 (8%) | 843 (10%) | |
No | 7743 (90%) | 327 (92%) | 7416 (90%) |
All Patients (n = 8615) | Metastasis Present (n = 356) | Metastasis Absent (n = 8259) | p | |
---|---|---|---|---|
Clinical features | ||||
Primary site | <0.001 | |||
Cerebrum | 709 (8%) | 20 (6%) | 689 (8%) | |
Frontal lobe | 768 (9%) | 7 (2%) | 761 (9%) | |
Temporal lobe | 817 (10%) | 14 (4%) | 803 (10%) | |
Parietal lobe | 356 (4%) | 5 (1%) | 351 (4%) | |
Occipital lobe | 185 (2%) | 1 (<1%) | 184 (2%) | |
Ventricle | 733 (8%) | 34 (10%) | 699 (9%) | |
Cerebellum | 1608 (19%) | 121 (34%) | 1487 (18%) | |
Brain stem | 1499 (17%) | 61 (17%) | 1438 (17%) | |
Overlapping lesion | 365 (4%) | 12 (3%) | 353 (4%) | |
Not specified | 1575 (18%) | 81 (23%) | 1494 (18%) | |
Primary WHO grade * | <0.001 | |||
1 | 2120 (40%) | 15 (6%) | 2105 (41%) | |
2 | 868 (16%) | 20 (8%) | 848 (17%) | |
3 | 720 (13%) | 23 (10%) | 697 (14%) | |
4 | 1616 (30%) | 178 (75%) | 1438 (28%) | |
Histology ** | <0.001 | |||
Medulloblastoma | 1118 (13%) | 164 (46%) | 954 (12%) | |
Malignant glioma | 1682 (20%) | 40 (11%) | 1642 (20%) | |
ATRT | 211 (2%) | 26 (7%) | 185 (2%) | |
Pilocytic astrocytoma | 1643 (19%) | 24 (7%) | 1819 (20%) | |
Ependymoma | 612 (7%) | 19 (5%) | 593 (7%) | |
Neuroblastoma | 26 (<1%) | 13 (4%) | 13 (<1%) | |
Primary site of metastasis *** | ||||
Brain | 60 (62%) | |||
Bone | 37 (38%) | |||
Treatment features | ||||
Surgery | <0.001 | |||
No, autopsy only | 2120 (25%) | 73 (21%) | 2047 (25%) | |
Yes | ||||
Biopsy | 1437 (17%) | 63 (18%) | 1374 (17%) | |
Subtotal resection | 1499 (17%) | 100 (28%) | 1399 (17%) | |
Gross total resection | 3559 (41%) | 120 (34%) | 3439 (42%) | |
Chemotherapy | <0.001 | |||
Yes | 3044 (35%) | 275 (77%) | 2769 (34%) | |
No | 5571 (65%) | 81 (23%) | 5490 (66%) | |
Radiation therapy | <0.001 | |||
Yes | 3127 (36%) | 212 (60%) | 2915 (35%) | |
No | 5488 (64%) | 144 (40%) | 5322 (65%) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lu, V.M.; Niazi, T.N. Characterizing the Natural History of Pediatric Brain Tumors Presenting with Metastasis. Cancers 2025, 17, 775. https://doi.org/10.3390/cancers17050775
Lu VM, Niazi TN. Characterizing the Natural History of Pediatric Brain Tumors Presenting with Metastasis. Cancers. 2025; 17(5):775. https://doi.org/10.3390/cancers17050775
Chicago/Turabian StyleLu, Victor M., and Toba N. Niazi. 2025. "Characterizing the Natural History of Pediatric Brain Tumors Presenting with Metastasis" Cancers 17, no. 5: 775. https://doi.org/10.3390/cancers17050775
APA StyleLu, V. M., & Niazi, T. N. (2025). Characterizing the Natural History of Pediatric Brain Tumors Presenting with Metastasis. Cancers, 17(5), 775. https://doi.org/10.3390/cancers17050775